Clément Gakuba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Clément Gakuba has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Jean-Luc Hanouz
Service d’anesthésie et réanimation chirurgicale, Centre Hospitalier Universitaire de Caen Normandie, Caen, Normandy, France
3 shared publications Damiano Cerasuolo
Département de santé publique, Centre hospitalier universitaire de Caen, Caen, France; and
2 shared publicationsDenis Vivien
UNICAEN, Caen Normandie Université,Inserm UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Institut Blood and Brain {at} Caen-Normandie (BB{at}C), Normandie University
2 shared publicationsJean-Denis Moyer
UNICAEN, Caen Normandie Université,Inserm UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Institut Blood and Brain {at} Caen-Normandie (BB{at}C), Normandie University
2 shared publicationsJean-Luc Hanouz
Département d’Anesthésie Réanimation, CHU de Caen Normandie, Caen, France
2 shared publicationsThomas Gaberel
2 shared publications
Latest Publications
- Open Access
- 3 October 2026
- Published by Wiley in Pain Practice
- Vol. 26 (8) , e70208
Pain Management in Older Adults: An Interprofessional Training Approach Assessed by Script Concordance Tests
Background: Optimal perioperative pain management in older adults challenges anesthesiologists due to increased drug sensitivity, altered pharmacokinetics, and limitations of pain assessment tools in cognitively impaired patients. This study evaluated whether a single 60‐min structured collaborative training session between a geriatrician and a clinical pharmacist is associated with improved anesthesiologists' clinical reasoning regarding perioperative analgesic management in older adults, as measured by increased concordance with expert opinion on a script concordance test (SCT). Methods: SCT assessed 20 clinical vignettes covering pain assessment, analgesic selection, and adverse effect management domains. These were submitted to anesthesiologists before and after training. A panel of 13 geriatricians established scoring criteria. Internal consistency was measured using Cronbach's alpha. Paired t ‐tests and Wilcoxon signed‐rank tests compared pre‐ and post‐training scores, with the 95% confidence interval (CI) for the overall change estimated by bootstrap resampling. Results: Seventeen anesthesiologists completed both assessments. Mean SCT scores increased from 45.8 ± 7.4 to 59.5 ± 8.5 post‐training ( p < 0.001), showing a 29.7% improvement (95% CI, 18.7%–41.7%). Analysis revealed improvements in analgesic prescription (+47.9%; 95% CI, 10.0–28.1 points) and adverse effect management (+26.8%; 95% CI, 9.1–19.0 points), while the change in pain assessment was not statistically significant (−11.6%; 95% CI, −16.6–9.4 points). Internal consistency improved from 0.542 to 0.704. Most participants (89.5%) lacked prior training in prescribing analgesics to older adults, and 73.7% were unfamiliar with clinical guidelines. Conclusion: This study suggests that collaborative geriatrician‐pharmacist training is associated with improved anesthesiologists' clinical reasoning regarding perioperative analgesic management in older adults, as measured by greater concordance with expert opinion on a script concordance test. The varying effects across domains suggest that distinct competencies may require distinct educational approaches. These findings support further investigation of interprofessional education into anesthesiology training to enhance clinical reasoning in the care of older surgical patients.
- 3 October 2026
- Published by Wiley in Pain Practice
- Vol. 26 (8) , e70208
Open AccessPain Management in Older Adults: An Interprofessional Training Approach Assessed by Script Concordance Tests
Background: Optimal perioperative pain management in older adults challenges anesthesiologists due to increased drug sensitivity, altered pharmacokinetics, and limitations of pain assessment tools in cognitively impaired patients. This study evaluated whether a single 60‐min structured collaborative training session between a geriatrician and a clinical pharmacist is associated with improved anesthesiologists' clinical reasoning regarding perioperative analgesic management in older adults, as measured by increased concordance with expert opinion on a script concordance test (SCT). Methods: SCT assessed 20 clinical vignettes covering pain assessment, analgesic selection, and adverse effect management domains. These were submitted to anesthesiologists before and after training. A panel of 13 geriatricians established scoring criteria. Internal consistency was measured using Cronbach's alpha. Paired t ‐tests and Wilcoxon signed‐rank tests compared pre‐ and post‐training scores, with the 95% confidence interval (CI) for the overall change estimated by bootstrap resampling. Results: Seventeen anesthesiologists completed both assessments. Mean SCT scores increased from 45.8 ± 7.4 to 59.5 ± 8.5 post‐training ( p < 0.001), showing a 29.7% improvement (95% CI, 18.7%–41.7%). Analysis revealed improvements in analgesic prescription (+47.9%; 95% CI, 10.0–28.1 points) and adverse effect management (+26.8%; 95% CI, 9.1–19.0 points), while the change in pain assessment was not statistically significant (−11.6%; 95% CI, −16.6–9.4 points). Internal consistency improved from 0.542 to 0.704. Most participants (89.5%) lacked prior training in prescribing analgesics to older adults, and 73.7% were unfamiliar with clinical guidelines. Conclusion: This study suggests that collaborative geriatrician‐pharmacist training is associated with improved anesthesiologists' clinical reasoning regarding perioperative analgesic management in older adults, as measured by greater concordance with expert opinion on a script concordance test. The varying effects across domains suggest that distinct competencies may require distinct educational approaches. These findings support further investigation of interprofessional education into anesthesiology training to enhance clinical reasoning in the care of older surgical patients.
- Open Access
- 14 May 2026
- Published by Elsevier in SSRN Electronic Journal
Intraventricular Fibrinolysis for Aneurysmal Subarachnoid Haemorrhage: A Randomized Trial and Individual Patient Data Meta-analysis
Purpose: Aneurysmal subarachnoid haemorrhage (aSAH) is a severe form of stroke. Clearing blood from the cerebrospinal fluid by intraventricular fibrinolysis (IVF) through an external ventricular drain (EVD) has been hypothesized to improve functional outcome. The aim of this study was to evaluate the effect of IVF on functional outcome after aSAH. Methods: FIVHeMA is a multicentre phase III randomized controlled trial (RCT). Patients with aSAH requiring EVD insertion were included. Patients were randomized to receive either EVD alone or IVF. The primary outcome was good functional outcome at 6 months, defined as modified Rankin Scale (mRS) 0–3. To increase statistical power, an individual patient data meta-analysis (IPD-MA) of similar RCT was also performed. Results: The trial was terminated early because the target enrolment of 440 participants was deemed not feasible. 84 patients were randomized: 44 to EVD alone and 40 to IVF. Primary outcome was achieved in 39/44 (89%) with EVD alone and 34/40 (85%) with IVF (OR=0.7, 95% CI 0.2–2.6; p=0.63). Secondary and safety outcomes were similar across groups. Non-significant reductions were observed in delayed neurological deficit (OR=0.4, 95% CI 0.1–1.1; p=0.065) and chronic hydrocephalus (OR=0.4, 95% CI 0.1–1.0; p=0.054) in the IVF group. In the IPD-MA combining 137 patients from 4 trials, good outcome was observed in 55/71 (77%) with IVF and 50/66 (76%) with EVD alone (Peto OR=1.4, 95% CI 0.6–3.3; p=0.42).Conclusions: This prematurely terminated trial, complemented by IPD-MA, found no evidence that IVF improves functional outcome after aSAH.
- 14 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessIntraventricular Fibrinolysis for Aneurysmal Subarachnoid Haemorrhage: A Randomized Trial and Individual Patient Data Meta-analysis
Purpose: Aneurysmal subarachnoid haemorrhage (aSAH) is a severe form of stroke. Clearing blood from the cerebrospinal fluid by intraventricular fibrinolysis (IVF) through an external ventricular drain (EVD) has been hypothesized to improve functional outcome. The aim of this study was to evaluate the effect of IVF on functional outcome after aSAH. Methods: FIVHeMA is a multicentre phase III randomized controlled trial (RCT). Patients with aSAH requiring EVD insertion were included. Patients were randomized to receive either EVD alone or IVF. The primary outcome was good functional outcome at 6 months, defined as modified Rankin Scale (mRS) 0–3. To increase statistical power, an individual patient data meta-analysis (IPD-MA) of similar RCT was also performed. Results: The trial was terminated early because the target enrolment of 440 participants was deemed not feasible. 84 patients were randomized: 44 to EVD alone and 40 to IVF. Primary outcome was achieved in 39/44 (89%) with EVD alone and 34/40 (85%) with IVF (OR=0.7, 95% CI 0.2–2.6; p=0.63). Secondary and safety outcomes were similar across groups. Non-significant reductions were observed in delayed neurological deficit (OR=0.4, 95% CI 0.1–1.1; p=0.065) and chronic hydrocephalus (OR=0.4, 95% CI 0.1–1.0; p=0.054) in the IVF group. In the IPD-MA combining 137 patients from 4 trials, good outcome was observed in 55/71 (77%) with IVF and 50/66 (76%) with EVD alone (Peto OR=1.4, 95% CI 0.6–3.3; p=0.42).Conclusions: This prematurely terminated trial, complemented by IPD-MA, found no evidence that IVF improves functional outcome after aSAH.
- 20 February 2026
- Published by Elsevier in Anesthésie & Réanimation
- Vol. 12 (2) , 190-203
Hypertension intracrânienne : ce que montrent les preuves, ce qui reste à prouver
- 20 February 2026
- Published by Elsevier in Anesthésie & Réanimation
- Vol. 12 (2) , 190-203
Hypertension intracrânienne : ce que montrent les preuves, ce qui reste à prouver
- Open Access
Bedside three-dimensional acoustic angiography and perfusion imaging for early detection of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: A Feasibility study
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening condition with high rates of secondary complications such as delayed cerebral ischemia (DCI). Early detection of perfusion deficits is critical but remains challenging with conventional imaging modalities that are intermittent, non-portable, and provide limited temporal resolution. Here, we evaluate a novel investigational platform for volumetric acoustic angiography and bedside cerebral perfusion imaging using three-dimensional contrast-enhanced ultrasound (3D CEUS). In a prospective feasibility study, eleven aSAH patients underwent bilateral 3D CEUS at admission, day 5, and day 10 in the neurocritical care unit. The system enabled reconstruction of 3D microvascular volumes and time-intensity evolution (TIE) curves for cerebral blood flow (CBF) assessment. Global perfusion measurements were successful in 95% of acquisitions. Notably, TIE-derived perfusion patterns at day 5 showed strong correlation with poor neurological outcome (88.9% accuracy) suggesting the prognostic potential of the technique. This study demonstrates, for the first time, the feasibility of bedside volumetric CEUS for dynamic assessment of cerebral perfusion in patients with aSAH. The method offers high spatial and temporal resolution, real-time feedback, and correlation with clinical trajectory. These findings position three dimensional CEUS-based acoustic angiography as a promising tool for early detection of DCI and improved neuromonitoring in the intensive care unit.
Open AccessBedside three-dimensional acoustic angiography and perfusion imaging for early detection of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: A Feasibility study
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening condition with high rates of secondary complications such as delayed cerebral ischemia (DCI). Early detection of perfusion deficits is critical but remains challenging with conventional imaging modalities that are intermittent, non-portable, and provide limited temporal resolution. Here, we evaluate a novel investigational platform for volumetric acoustic angiography and bedside cerebral perfusion imaging using three-dimensional contrast-enhanced ultrasound (3D CEUS). In a prospective feasibility study, eleven aSAH patients underwent bilateral 3D CEUS at admission, day 5, and day 10 in the neurocritical care unit. The system enabled reconstruction of 3D microvascular volumes and time-intensity evolution (TIE) curves for cerebral blood flow (CBF) assessment. Global perfusion measurements were successful in 95% of acquisitions. Notably, TIE-derived perfusion patterns at day 5 showed strong correlation with poor neurological outcome (88.9% accuracy) suggesting the prognostic potential of the technique. This study demonstrates, for the first time, the feasibility of bedside volumetric CEUS for dynamic assessment of cerebral perfusion in patients with aSAH. The method offers high spatial and temporal resolution, real-time feedback, and correlation with clinical trajectory. These findings position three dimensional CEUS-based acoustic angiography as a promising tool for early detection of DCI and improved neuromonitoring in the intensive care unit.
- 27 November 2024
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 117 (3) , 742-748
Oxygenation Effects of Antihypertensive Agents in Intensive Care: A Prospective Comparative Study of Nicardipine and Urapidil
Acute arterial hypertension within the critical care context may necessitate the administration of intravenous antihypertensive agents. Nicardipine and urapidil are notable for their application in intensive care units. Nonetheless, dihydropyridine calcium channel inhibitors (DCCIs) such as nicardipine are implicated in the impairment of hypoxic pulmonary vasoconstriction, potentially disrupting oxygenation. This study aimed to assess the differences in patient oxygenation when these antihypertensive agents are administered intravenously. This bicentric, prospective, observational investigation spanning five intensive care units evaluated patients requiring intravenous nicardipine or urapidil. Oxygenation data were recorded from the start of therapy until the 12th hour. Comparative analysis was performed between patient groups based on the antihypertensive agent administered, along with subgroup investigations to identify populations with an elevated risk of hypoxemia. From November 2021 to November 2023, 197 patients were included: 98 (50%) were treated with nicardipine, and 99 (50%) were treated with urapidil. Hypoxemia occurred in 97 (49%) patients and was more prevalent in the nicardipine cohort, affecting 65 (66%) patients, as opposed to 32 (32%) patients in the urapidil cohort (RR 2.05, 95% CI [1.48–2.82], P < 0.001). Subgroup analysis revealed a significant association between patients with pulmonary atelectasis (RR 2.30, 95% CI [1.4–3.7], P < 0.001) and obesity (RR 2.7, 95% CI [1.5–4.6], P < 0.001). Considering these findings, cautious consideration of the patient's respiratory status should be exercised when initiating intravenous DCCI treatment. However, given the limitations of this study, a controlled trial on hypertension management in the ICU is needed.
- 27 November 2024
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 117 (3) , 742-748
Oxygenation Effects of Antihypertensive Agents in Intensive Care: A Prospective Comparative Study of Nicardipine and Urapidil
Acute arterial hypertension within the critical care context may necessitate the administration of intravenous antihypertensive agents. Nicardipine and urapidil are notable for their application in intensive care units. Nonetheless, dihydropyridine calcium channel inhibitors (DCCIs) such as nicardipine are implicated in the impairment of hypoxic pulmonary vasoconstriction, potentially disrupting oxygenation. This study aimed to assess the differences in patient oxygenation when these antihypertensive agents are administered intravenously. This bicentric, prospective, observational investigation spanning five intensive care units evaluated patients requiring intravenous nicardipine or urapidil. Oxygenation data were recorded from the start of therapy until the 12th hour. Comparative analysis was performed between patient groups based on the antihypertensive agent administered, along with subgroup investigations to identify populations with an elevated risk of hypoxemia. From November 2021 to November 2023, 197 patients were included: 98 (50%) were treated with nicardipine, and 99 (50%) were treated with urapidil. Hypoxemia occurred in 97 (49%) patients and was more prevalent in the nicardipine cohort, affecting 65 (66%) patients, as opposed to 32 (32%) patients in the urapidil cohort (RR 2.05, 95% CI [1.48–2.82], P < 0.001). Subgroup analysis revealed a significant association between patients with pulmonary atelectasis (RR 2.30, 95% CI [1.4–3.7], P < 0.001) and obesity (RR 2.7, 95% CI [1.5–4.6], P < 0.001). Considering these findings, cautious consideration of the patient's respiratory status should be exercised when initiating intravenous DCCI treatment. However, given the limitations of this study, a controlled trial on hypertension management in the ICU is needed.
- 1 June 2024
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 83 (6) , 580-587
N-Acetylcysteine to Reduce Mortality for Patients Requiring Cardiac Catheterization or Cardiac Surgery: A Systematic Review and Meta-analysis
Multimers of von Willebrand factor play a critical role in various processes inducing morbidity and mortality in cardiovascular-risk patients. With the ability to reduce von Willebrand factor multimers, N-acetylcysteine (NAC) could reduce mortality in patients undergoing coronary catheterization or cardiac surgery. However, its impact in perioperative period has never been studied so far in regard of its potential cardiovascular benefits. Then, 4 databases were searched for randomized controlled trials that compared in-hospital mortality between an experimental group, with NAC, and a control group without NAC, in patients undergoing coronary catheterization or cardiac surgery. The primary efficacy outcome was in-hospital mortality. Secondary outcomes were the occurrence of thrombotic events, major cardiovascular events, myocardial infarction, and contrast-induced nephropathy. The safety outcome was occurrence of hemorrhagic events. Nineteen studies totaling 3718 patients were included. Pooled analysis demonstrated a reduction of in-hospital mortality associated with NAC: odds ratio, 0.60; 95% confidence interval, 0.39–0.92; P = 0.02. The occurrence of secondary outcomes was not significantly reduced with NAC except for contrast-induced nephropathy. No difference was reported for hemorrhagic events. Subgroup analyses revealed a life-saving effect of NAC in a dose-dependent manner with reduction of in-hospital mortality for the NAC high-dose group, but not for the NAC standard-dose (<3500-mg) group. In conclusion, without being able to conclude on the nature of the mechanism involved, our review suggests a benefit of NAC in cardiovascular-risk patients in perioperative period in terms of mortality and supports prospective confirmatory studies.
- 1 June 2024
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 83 (6) , 580-587
N-Acetylcysteine to Reduce Mortality for Patients Requiring Cardiac Catheterization or Cardiac Surgery: A Systematic Review and Meta-analysis
Multimers of von Willebrand factor play a critical role in various processes inducing morbidity and mortality in cardiovascular-risk patients. With the ability to reduce von Willebrand factor multimers, N-acetylcysteine (NAC) could reduce mortality in patients undergoing coronary catheterization or cardiac surgery. However, its impact in perioperative period has never been studied so far in regard of its potential cardiovascular benefits. Then, 4 databases were searched for randomized controlled trials that compared in-hospital mortality between an experimental group, with NAC, and a control group without NAC, in patients undergoing coronary catheterization or cardiac surgery. The primary efficacy outcome was in-hospital mortality. Secondary outcomes were the occurrence of thrombotic events, major cardiovascular events, myocardial infarction, and contrast-induced nephropathy. The safety outcome was occurrence of hemorrhagic events. Nineteen studies totaling 3718 patients were included. Pooled analysis demonstrated a reduction of in-hospital mortality associated with NAC: odds ratio, 0.60; 95% confidence interval, 0.39–0.92; P = 0.02. The occurrence of secondary outcomes was not significantly reduced with NAC except for contrast-induced nephropathy. No difference was reported for hemorrhagic events. Subgroup analyses revealed a life-saving effect of NAC in a dose-dependent manner with reduction of in-hospital mortality for the NAC high-dose group, but not for the NAC standard-dose (<3500-mg) group. In conclusion, without being able to conclude on the nature of the mechanism involved, our review suggests a benefit of NAC in cardiovascular-risk patients in perioperative period in terms of mortality and supports prospective confirmatory studies.
- Open Access
- 6 May 2024
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 43 (4) , 101387
Preoperative ketamine administration for prevention of postoperative neurocognitive disorders after major orthopedic surgery in elderly patients: A multicenter randomized blinded placebo-controlled trial
- 6 May 2024
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 43 (4) , 101387
Open AccessPreoperative ketamine administration for prevention of postoperative neurocognitive disorders after major orthopedic surgery in elderly patients: A multicenter randomized blinded placebo-controlled trial
- 6 March 2024
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 52 (6) , 942-950
Evaluation of ChatGPT in Predicting 6-Month Outcomes After Traumatic Brain Injury*
OBJECTIVES: To evaluate the capacity of ChatGPT, a widely accessible and uniquely popular artificial intelligence-based chatbot, in predicting the 6-month outcome following moderate-to-severe traumatic brain injury (TBI). DESIGN: Single-center observational retrospective study. SETTING: Data are from a neuro-ICU from a level 1 trauma center. PATIENTS: All TBI patients admitted to ICU between September 2021 and October 2022 were included in a prospective database. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Based on anonymized clinical, imaging, and biological information available at the patients’ hospital admission and extracted from the database, clinical vignettes were retrospectively submitted to ChatGPT for prediction of patients’ outcomes. The predictions of two intensivists (one neurointensivist and one non-neurointensivist) both from another level 1 trauma center (Beaujon Hospital), were also collected as was the International Mission on Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) scoring. Each intensivist, as well as ChatGPT, made their prognostic evaluations independently, without knowledge of the others’ predictions and of the patients’ actual management and outcome. Both the intensivists and ChatGPT were given access to the exact same set of information. The main outcome was a 6-month-functional status dichotomized into favorable (Glasgow Outcome Scale Extended [GOSE] ≥ 5) versus poor (GOSE < 5). Prediction of intracranial hypertension management, pulmonary infectious risk, and removal of life-sustaining therapies was also investigated as secondary outcomes. Eighty consecutive moderate-to-severe TBI patients were included. For the 6-month outcome prognosis, area under the receiver operating characteristic curve (AUC-ROC) for ChatGPT, the neurointensivist, the non-neurointensivist, and IMPACT were, respectively, 0.62 (0.50–0.74), 0.70 (0.59–0.82), 0.71 (0.59–0.82), and 0.81 (0.72–0.91). ChatGPT had the highest sensitivity (100%), but the lowest specificity (26%). For secondary outcomes, ChatGPT’s prognoses were generally less accurate than clinicians’ prognoses, with lower AUC values for most outcomes. CONCLUSIONS: This study does not support the use of ChatGPT for prediction of outcomes after TBI.
- 6 March 2024
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 52 (6) , 942-950
Evaluation of ChatGPT in Predicting 6-Month Outcomes After Traumatic Brain Injury*
OBJECTIVES: To evaluate the capacity of ChatGPT, a widely accessible and uniquely popular artificial intelligence-based chatbot, in predicting the 6-month outcome following moderate-to-severe traumatic brain injury (TBI). DESIGN: Single-center observational retrospective study. SETTING: Data are from a neuro-ICU from a level 1 trauma center. PATIENTS: All TBI patients admitted to ICU between September 2021 and October 2022 were included in a prospective database. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Based on anonymized clinical, imaging, and biological information available at the patients’ hospital admission and extracted from the database, clinical vignettes were retrospectively submitted to ChatGPT for prediction of patients’ outcomes. The predictions of two intensivists (one neurointensivist and one non-neurointensivist) both from another level 1 trauma center (Beaujon Hospital), were also collected as was the International Mission on Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) scoring. Each intensivist, as well as ChatGPT, made their prognostic evaluations independently, without knowledge of the others’ predictions and of the patients’ actual management and outcome. Both the intensivists and ChatGPT were given access to the exact same set of information. The main outcome was a 6-month-functional status dichotomized into favorable (Glasgow Outcome Scale Extended [GOSE] ≥ 5) versus poor (GOSE < 5). Prediction of intracranial hypertension management, pulmonary infectious risk, and removal of life-sustaining therapies was also investigated as secondary outcomes. Eighty consecutive moderate-to-severe TBI patients were included. For the 6-month outcome prognosis, area under the receiver operating characteristic curve (AUC-ROC) for ChatGPT, the neurointensivist, the non-neurointensivist, and IMPACT were, respectively, 0.62 (0.50–0.74), 0.70 (0.59–0.82), 0.71 (0.59–0.82), and 0.81 (0.72–0.91). ChatGPT had the highest sensitivity (100%), but the lowest specificity (26%). For secondary outcomes, ChatGPT’s prognoses were generally less accurate than clinicians’ prognoses, with lower AUC values for most outcomes. CONCLUSIONS: This study does not support the use of ChatGPT for prediction of outcomes after TBI.
- 28 August 2023
- Published by Elsevier in Anesthésie & Réanimation
- Vol. 9 (4) , 305-309
Directives anticipées en réanimation : illusions perdues ou l’opportunité d’un renouveau ?
- 28 August 2023
- Published by Elsevier in Anesthésie & Réanimation
- Vol. 9 (4) , 305-309
Directives anticipées en réanimation : illusions perdues ou l’opportunité d’un renouveau ?
- 1 October 2021
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 40 (5) , 100936
Effect of patient-controlled epidural analgesia with and without automatic intermittent bolus on levobupivacaine consumption during labour: A single-centre prospective double-blinded randomised controlled study
- 1 October 2021
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 40 (5) , 100936
Effect of patient-controlled epidural analgesia with and without automatic intermittent bolus on levobupivacaine consumption during labour: A single-centre prospective double-blinded randomised controlled study